EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antiviral Effects of Tecovirimat and Cellular Ultrastructural Changes in Human Bronchial Epithelial Cell Line Following Monkeypox Virus Infection

Laura Falasca iD, Cosmina Mija, Giuseppe Sberna iD, Massimo Francalancia iD, Silvia Meschi iD, Valentina Mazzotta iD, Enrico Girardi iD, Andrea Antinori iD, Fabrizio Maggi iD, Licia Bordi

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26062718 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Laura Falasca und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Electron Microscopy, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, 00149 Rome, Italy. Hauptthemen laut MEDLINE: Antiviral Agents, Epithelial Cells, Bronchi, Monkeypox virus. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero della Salute, National Institute for Infectious Diseases “Lazzaro Spallanzani”.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The mpox virus (MPXV) Clade IIb outbreak in 2022 was the biggest one ever to occur outside Africa, causing different types of clinical symptoms and levels of disease severity. There is no currently approved treatment for mpox, but Tecovirimat has proven effective against known orthopoxviruses in several animal models and Vero cell cultures. Since serious complications, including lung involvement, have been reported, especially in immunocompromised people, we investigated the effects of MPXV infection on the in vitro model of lung airway epithelium (Calu-3 cell line) and examined MPXV replication kinetic and related ultrastructural changes, also performing dose–response studies to measure Tecovirimat antiviral activity. Our results highlighted an active replication of MPXV in Calu-3 cells linked to mitochondrial structural modifications with perinuclear relocation and the formation of cytoplasmic vacuoles. Treatment with Tecovirimat consistently reduced viral replication both in supernatants (81%) and inside cells (77%) and ultimately stopped viral infectivity (92% of cytopathic effect reduction) after 48 h of infection. Drug administration inhibited the final wrapping of mature viral particles, causing extensive cytoplasmic vacuolation. Our results demonstrated Tecovirimat’s in vitro effectiveness against MPXV at the nanomolar concentration on Calu-3 cells. This suggests a potential rationale for using this drug for patients with mpox severe disease and lung involvement.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsEpithelial CellsBronchiMonkeypox virusBenzamidesHumansVirus ReplicationCell LineChlorocebus aethiopsAnimals

Stichwörter der Autor:innen

Calu-3 cellsMPXVantiviral activityelectron microscopymitochondriampox diseasetecovirimat

Substanzen

Antiviral AgentsBenzamides

Autor:innen und Institutionen

  • Laboratory of Electron Microscopy, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, 00149 Rome, Italy.
  • Laboratory of Virology and Biosafety Laboratories, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, 00149 Rome, Italy.
  • Microbiology and Virology Unit, San Gallicano Dermatological Institute-IRCCS, Istituti Fisioterapici Ospitalieri (IFO), 00144 Rome, Italy.
  • Clinical Department, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, 00149 Rome, Italy.
  • Scientific Direction, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, 00149 Rome, Italy.

ORCID-Profile: Laura Falasca, Giuseppe Sberna, Massimo Francalancia, Silvia Meschi, Valentina Mazzotta, Enrico Girardi, Andrea Antinori, Fabrizio Maggi

Förderung

  • Ministero della Salute
  • National Institute for Infectious Diseases “Lazzaro Spallanzani”

Zitieren

APA

Falasca, L., Mija, C., Sberna, G., Francalancia, M., Meschi, S., Mazzotta, V., Girardi, E., Antinori, A., Maggi, F., & Bordi, L. (2025). Antiviral Effects of Tecovirimat and Cellular Ultrastructural Changes in Human Bronchial Epithelial Cell Line Following Monkeypox Virus Infection. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26062718

Vancouver

Falasca L, Mija C, Sberna G, Francalancia M, Meschi S, Mazzotta V, et al. Antiviral Effects of Tecovirimat and Cellular Ultrastructural Changes in Human Bronchial Epithelial Cell Line Following Monkeypox Virus Infection. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26062718

BibTeX
@article{Falasca2025,
  author = {Falasca, Laura and Mija, Cosmina and Sberna, Giuseppe and Francalancia, Massimo and Meschi, Silvia and Mazzotta, Valentina and Girardi, Enrico and Antinori, Andrea and Maggi, Fabrizio and Bordi, Licia},
  title = {Antiviral Effects of Tecovirimat and Cellular Ultrastructural Changes in Human Bronchial Epithelial Cell Line Following Monkeypox Virus Infection},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26062718}
}
Kostenlos starten →